https://dibagen.com/2026/10/06/charge-switching-lipids-mrna-delivery/2026-10-06T01:29:20+03:30https://dibagen.com/2026/10/06/charge-switching-lipids-mrna-delivery-fa/2026-10-06T01:29:27+03:30https://dibagen.com/2026/10/06/charge-switching-lipids-mrna-delivery-ar/2026-10-06T01:29:34+03:30https://dibagen.com/2026/10/06/ai-guided-heat-stable-mrna-vaccines/2026-10-06T13:38:35+03:30https://dibagen.com/2026/10/06/ai-guided-heat-stable-mrna-vaccines-fa/2026-10-06T13:38:40+03:30https://dibagen.com/2026/10/06/ai-guided-heat-stable-mrna-vaccines-ar/2026-10-06T13:38:44+03:30https://dibagen.com/2026/10/06/mrna-translation-fidelity-sequence-design/2026-10-06T17:25:12+03:30https://dibagen.com/2026/10/06/mrna-translation-fidelity-sequence-design-fa/2026-10-06T17:25:21+03:30https://dibagen.com/2026/10/06/mrna-translation-fidelity-sequence-design-ar/2026-10-06T17:25:31+03:30https://dibagen.com/2026/10/06/achievement-vaccine-antigen-selection-review/2026-10-06T18:25:08+03:30https://dibagen.com/2026/10/06/achievement-vaccine-antigen-selection-review-fa/2026-10-06T18:25:17+03:30https://dibagen.com/2026/10/06/achievement-vaccine-antigen-selection-review-ar/2026-10-06T18:25:25+03:30https://dibagen.com/2026/10/06/achievement-targeted-cytosolic-mrna-delivery/2026-10-06T18:25:46+03:30https://dibagen.com/2026/10/06/achievement-targeted-cytosolic-mrna-delivery-fa/2026-10-06T18:26:01+03:30https://dibagen.com/2026/10/06/achievement-targeted-cytosolic-mrna-delivery-ar/2026-10-06T18:26:12+03:30https://dibagen.com/2026/10/06/achievement-tabs-science-writing-winner-2026/2026-10-06T18:30:26+03:30https://dibagen.com/2026/10/06/achievement-tabs-science-writing-winner-2026-fa/2026-10-06T18:30:34+03:30https://dibagen.com/2026/10/06/achievement-tabs-science-writing-winner-2026-ar/2026-10-06T18:30:42+03:30https://dibagen.com/2026/10/06/gastrointestinal-mrna-delivery-pancreas-vaccines/2026-10-06T22:57:02+03:30https://dibagen.com/2026/10/06/gastrointestinal-mrna-delivery-pancreas-vaccines-fa/2026-10-06T22:57:08+03:30https://dibagen.com/2026/10/06/gastrointestinal-mrna-delivery-pancreas-vaccines-ar/2026-10-06T22:57:17+03:30https://dibagen.com/2026/10/07/mrna-manufacturing-reagent-recycling/2026-10-07T09:32:04+03:30https://dibagen.com/2026/10/07/mrna-manufacturing-reagent-recycling-fa/2026-10-07T09:32:09+03:30https://dibagen.com/2026/10/07/mrna-manufacturing-reagent-recycling-ar/2026-10-07T09:32:14+03:30https://dibagen.com/2026/10/07/breast-cancer-disease-guide/2026-10-07T12:58:59+03:30https://dibagen.com/2026/10/07/breast-cancer-disease-guide-fa/2026-10-07T12:59:10+03:30https://dibagen.com/2026/10/07/breast-cancer-disease-guide-ar/2026-10-07T12:59:18+03:30https://dibagen.com/2026/10/07/large-rna-cargo-lc1-gene-editing/2026-10-07T19:40:08+03:30https://dibagen.com/2026/10/07/large-rna-cargo-lc1-gene-editing-fa/2026-10-07T19:40:12+03:30https://dibagen.com/2026/10/07/large-rna-cargo-lc1-gene-editing-ar/2026-10-07T19:40:36+03:30https://dibagen.com/2026/10/08/mettl14-cell-cycle-rna-methylation/2026-10-08T09:11:22+03:30https://dibagen.com/2026/10/08/mettl14-cell-cycle-rna-methylation-fa/2026-10-08T09:11:30+03:30https://dibagen.com/2026/10/08/mettl14-cell-cycle-rna-methylation-ar/2026-10-08T09:11:34+03:30https://dibagen.com/2026/10/08/hepatitis-b-disease-primer/2026-10-08T09:18:21+03:30https://dibagen.com/2026/10/08/hepatitis-b-disease-primer-fa/2026-10-08T09:18:25+03:30https://dibagen.com/2026/10/08/hepatitis-b-disease-primer-ar/2026-10-08T09:18:28+03:30https://dibagen.com/2026/10/08/local-mrna-colitis-mp2-lipid/2026-10-08T12:42:15+03:30https://dibagen.com/2026/10/08/local-mrna-colitis-mp2-lipid-fa/2026-10-08T12:42:21+03:30https://dibagen.com/2026/10/08/local-mrna-colitis-mp2-lipid-ar/2026-10-08T12:42:26+03:30https://dibagen.com/2026/10/08/tuberculosis-disease-primer/2026-10-08T12:42:30+03:30https://dibagen.com/2026/10/08/tuberculosis-disease-primer-fa/2026-10-08T12:42:34+03:30https://dibagen.com/2026/10/08/tuberculosis-disease-primer-ar/2026-10-08T12:42:40+03:30https://dibagen.com/2026/10/08/russia-plague-irkutsk-what-we-know/2026-10-08T12:54:21+03:30https://dibagen.com/2026/10/08/russia-plague-irkutsk-what-we-know-fa/2026-10-08T12:54:25+03:30https://dibagen.com/2026/10/08/russia-plague-irkutsk-what-we-know-ar/2026-10-08T12:54:29+03:30https://dibagen.com/2026/10/08/stv-c8-ai-protein-mrna-delivery/2026-10-08T16:45:12+03:30https://dibagen.com/2026/10/08/stv-c8-ai-protein-mrna-delivery-fa/2026-10-08T16:45:18+03:30https://dibagen.com/2026/10/08/stv-c8-ai-protein-mrna-delivery-ar/2026-10-08T16:45:23+03:30https://dibagen.com/2026/10/09/beta-thalassemia-disease-primer/2026-10-09T10:15:43+03:30https://dibagen.com/2026/10/09/beta-thalassemia-disease-primer-fa/2026-10-09T10:15:46+03:30https://dibagen.com/2026/10/09/beta-thalassemia-disease-primer-ar/2026-10-09T10:15:50+03:30https://dibagen.com/2026/10/09/sensible-cell-made-mrna-manufacturing/2026-10-09T10:30:36+03:30https://dibagen.com/2026/10/09/sensible-cell-made-mrna-manufacturing-fa/2026-10-09T10:30:41+03:30https://dibagen.com/2026/10/09/sensible-cell-made-mrna-manufacturing-ar/2026-10-09T10:30:44+03:30https://dibagen.com/2026/10/09/nobel-medicine-2026-optogenetics/2026-10-09T14:28:17+03:30https://dibagen.com/2026/10/09/nobel-medicine-2026-optogenetics-fa/2026-10-09T14:28:22+03:30https://dibagen.com/2026/10/09/nobel-medicine-2026-optogenetics-ar/2026-10-09T14:28:27+03:30https://dibagen.com/2026/10/09/self-amplifying-rna-pku-mouse-study-en/2026-10-09T16:48:31+03:30https://dibagen.com/2026/10/09/self-amplifying-rna-pku-mouse-study-fa/2026-10-09T16:48:37+03:30https://dibagen.com/2026/10/09/self-amplifying-rna-pku-mouse-study-ar/2026-10-09T16:48:42+03:30https://dibagen.com/2026/10/09/phenylketonuria-pku-inheritance-screening-care-en/2026-10-09T16:48:47+03:30https://dibagen.com/2026/10/09/phenylketonuria-pku-inheritance-screening-care-fa/2026-10-09T16:48:51+03:30https://dibagen.com/2026/10/09/phenylketonuria-pku-inheritance-screening-care-ar/2026-10-09T16:48:58+03:30https://dibagen.com/2026/10/09/hybrid-vesicles-opg-mrna-osteoporotic-bone-en/2026-10-09T23:02:22+03:30https://dibagen.com/2026/10/09/hybrid-vesicles-opg-mrna-osteoporotic-bone-fa/2026-10-09T23:02:28+03:30https://dibagen.com/2026/10/09/hybrid-vesicles-opg-mrna-osteoporotic-bone-ar/2026-10-09T23:02:35+03:30https://dibagen.com/2026/10/10/mimac-rna-positioning-lipid-nanoparticles-en/2026-10-10T08:17:26+03:30https://dibagen.com/2026/10/10/mimac-rna-positioning-lipid-nanoparticles-fa/2026-10-10T08:17:29+03:30https://dibagen.com/2026/10/10/mimac-rna-positioning-lipid-nanoparticles-ar/2026-10-10T08:17:32+03:30https://dibagen.com/2026/10/10/colorectal-cancer-polyps-screening-care-en/2026-10-10T10:21:25+03:30https://dibagen.com/2026/10/10/colorectal-cancer-polyps-screening-care-fa/2026-10-10T10:21:32+03:30https://dibagen.com/2026/10/10/colorectal-cancer-polyps-screening-care-ar/2026-10-10T10:21:38+03:30https://dibagen.com/2026/10/10/antisense-rna-termination-window-en/2026-10-10T22:28:26+03:30https://dibagen.com/2026/10/10/antisense-rna-termination-window-fa/2026-10-10T22:28:33+03:30https://dibagen.com/2026/10/10/antisense-rna-termination-window-ar/2026-10-10T22:28:38+03:30https://dibagen.com/2026/10/11/coronary-artery-disease-plaque-prevention-en/2026-10-11T08:10:16+03:30https://dibagen.com/2026/10/11/coronary-artery-disease-plaque-prevention-fa/2026-10-11T08:10:23+03:30https://dibagen.com/2026/10/11/coronary-artery-disease-plaque-prevention-ar/2026-10-11T08:10:28+03:30https://dibagen.com/2026/10/11/nanoready-modular-mrna-cancer-vaccine-en/2026-10-18T20:51:29+03:30https://dibagen.com/2026/10/11/nanoready-modular-mrna-cancer-vaccine-fa/2026-10-18T20:52:24+03:30https://dibagen.com/2026/10/11/nanoready-modular-mrna-cancer-vaccine-ar/2026-10-18T20:52:41+03:30https://dibagen.com/2026/10/16/acute-myeloid-leukemia-genes-marrow-treatment-en/2026-10-16T22:30:57+03:30https://dibagen.com/2026/10/16/acute-myeloid-leukemia-genes-marrow-treatment-fa/2026-10-16T22:31:14+03:30https://dibagen.com/2026/10/16/acute-myeloid-leukemia-genes-marrow-treatment-ar/2026-10-16T22:31:18+03:30https://dibagen.com/2026/10/16/bnt113-ahead-merit-pfs-overall-survival-en/2026-10-16T22:31:22+03:30https://dibagen.com/2026/10/16/bnt113-ahead-merit-pfs-overall-survival-fa/2026-10-16T22:31:26+03:30https://dibagen.com/2026/10/16/bnt113-ahead-merit-pfs-overall-survival-ar/2026-10-16T22:31:29+03:30https://dibagen.com/2026/10/17/mrna-blood-stability-transcript-integrity-en/2026-10-17T09:24:14+03:30https://dibagen.com/2026/10/17/mrna-blood-stability-transcript-integrity-fa/2026-10-17T09:24:20+03:30https://dibagen.com/2026/10/17/mrna-blood-stability-transcript-integrity-ar/2026-10-17T09:24:27+03:30https://dibagen.com/2026/10/17/pancreatic-cancer-genes-symptoms-treatment-en/2026-10-17T09:24:33+03:30https://dibagen.com/2026/10/17/pancreatic-cancer-genes-symptoms-treatment-fa/2026-10-17T09:24:39+03:30https://dibagen.com/2026/10/17/pancreatic-cancer-genes-symptoms-treatment-ar/2026-10-17T09:24:45+03:30https://dibagen.com/2026/10/17/repeat-dose-mrna-delivery-peg-immunity-en/2026-10-17T20:09:54+03:30https://dibagen.com/2026/10/17/repeat-dose-mrna-delivery-peg-immunity-fa/2026-10-17T20:10:23+03:30https://dibagen.com/2026/10/17/repeat-dose-mrna-delivery-peg-immunity-ar/2026-10-17T20:10:35+03:30https://dibagen.com/2026/10/17/chemrna-short-rna-antigen-t-cells-en/2026-10-18T20:53:33+03:30https://dibagen.com/2026/10/17/chemrna-short-rna-antigen-t-cells-fa/2026-10-17T20:10:54+03:30https://dibagen.com/2026/10/17/chemrna-short-rna-antigen-t-cells-ar/2026-10-17T20:10:57+03:30https://dibagen.com/2026/10/18/heart-failure-pumping-filling-genes-care-en/2026-10-18T11:11:48+03:30https://dibagen.com/2026/10/18/heart-failure-pumping-filling-genes-care-fa/2026-10-18T11:11:53+03:30https://dibagen.com/2026/10/18/heart-failure-pumping-filling-genes-care-ar/2026-10-18T11:11:57+03:30https://dibagen.com/2026/10/18/mrna-quality-integrity-purity-potency-explained-en/2026-10-18T11:12:01+03:30https://dibagen.com/2026/10/18/mrna-quality-integrity-purity-potency-explained-fa/2026-10-18T11:12:05+03:30https://dibagen.com/2026/10/18/mrna-quality-integrity-purity-potency-explained-ar/2026-10-18T11:12:09+03:30https://dibagen.com/2026/10/19/ribo-m-engineered-ribosome-rna-message-en/2026-10-19T08:21:46+03:30https://dibagen.com/2026/10/19/ribo-m-engineered-ribosome-rna-message-fa/2026-10-19T08:21:49+03:30https://dibagen.com/2026/10/19/ribo-m-engineered-ribosome-rna-message-ar/2026-10-19T08:21:28+03:30https://dibagen.com/2026/10/20/stomach-cancer-h-pylori-genes-diagnosis-treatment-en/2026-10-20T09:03:56+03:30https://dibagen.com/2026/10/20/stomach-cancer-h-pylori-genes-diagnosis-treatment-fa/2026-10-20T09:04:02+03:30https://dibagen.com/2026/10/20/stomach-cancer-h-pylori-genes-diagnosis-treatment-ar/2026-10-20T09:04:09+03:30https://dibagen.com/2026/10/20/car-nk-mrna-targeted-lipid-nanoparticles-mouse-study-en/2026-10-20T09:04:15+03:30https://dibagen.com/2026/10/20/car-nk-mrna-targeted-lipid-nanoparticles-mouse-study-fa/2026-10-20T09:04:19+03:30https://dibagen.com/2026/10/20/car-nk-mrna-targeted-lipid-nanoparticles-mouse-study-ar/2026-10-20T09:04:24+03:30https://dibagen.com/2026/10/20/mrna-cancer-trials-response-pfs-overall-survival-en/2026-10-20T09:04:28+03:30https://dibagen.com/2026/10/20/mrna-cancer-trials-response-pfs-overall-survival-fa/2026-10-20T09:04:33+03:30https://dibagen.com/2026/10/20/mrna-cancer-trials-response-pfs-overall-survival-ar/2026-10-20T09:04:42+03:30https://dibagen.com/2026/10/21/multiple-myeloma-bone-kidney-diagnosis-treatment-en/2026-10-21T14:05:09+03:30https://dibagen.com/2026/10/21/multiple-myeloma-bone-kidney-diagnosis-treatment-fa/2026-10-21T14:05:15+03:30https://dibagen.com/2026/10/21/multiple-myeloma-bone-kidney-diagnosis-treatment-ar/2026-10-21T14:05:24+03:30https://dibagen.com/2026/10/21/p53-mrna-strontium-sulfite-lipid-hybrid-mouse-study-en/2026-10-21T14:05:58+03:30https://dibagen.com/2026/10/21/p53-mrna-strontium-sulfite-lipid-hybrid-mouse-study-fa/2026-10-21T14:06:06+03:30https://dibagen.com/2026/10/21/p53-mrna-strontium-sulfite-lipid-hybrid-mouse-study-ar/2026-10-21T14:06:11+03:30https://dibagen.com/2026/10/21/rna-editing-adar-guide-rna-explained-en/2026-10-21T14:06:49+03:30https://dibagen.com/2026/10/21/rna-editing-adar-guide-rna-explained-fa/2026-10-21T14:06:58+03:30https://dibagen.com/2026/10/21/rna-editing-adar-guide-rna-explained-ar/2026-10-21T14:07:04+03:30https://dibagen.com/2026/10/22/inhaled-mrna-nebulization-lipid-polymer-respiratory-models-en/2026-10-22T14:26:24+03:30https://dibagen.com/2026/10/22/inhaled-mrna-nebulization-lipid-polymer-respiratory-models-fa/2026-10-22T14:26:30+03:30https://dibagen.com/2026/10/22/inhaled-mrna-nebulization-lipid-polymer-respiratory-models-ar/2026-10-22T14:26:36+03:30https://dibagen.com/2026/10/22/hpv-positive-test-cancer-vaccine-screening-explained-en/2026-10-22T14:26:45+03:30https://dibagen.com/2026/10/22/hpv-positive-test-cancer-vaccine-screening-explained-fa/2026-10-22T14:26:54+03:30https://dibagen.com/2026/10/22/hpv-positive-test-cancer-vaccine-screening-explained-ar/2026-10-22T14:27:01+03:30https://dibagen.com/2026/10/23/moderna-msd-phase-3-melanoma-42-percent-interpath-001-en/2026-10-23T12:35:16+03:30https://dibagen.com/2026/10/23/moderna-msd-phase-3-melanoma-42-percent-interpath-001-fa/2026-10-23T12:35:24+03:30https://dibagen.com/2026/10/23/moderna-msd-phase-3-melanoma-42-percent-interpath-001-ar/2026-10-23T12:35:30+03:30https://dibagen.com/2026/10/24/amplify-7p-pancreatic-cancer-vaccine-primary-endpoint-en/2026-10-24T12:34:06+03:30https://dibagen.com/2026/10/24/amplify-7p-pancreatic-cancer-vaccine-primary-endpoint-fa/2026-10-24T12:34:20+03:30https://dibagen.com/2026/10/24/amplify-7p-pancreatic-cancer-vaccine-primary-endpoint-ar/2026-10-24T12:34:27+03:30https://dibagen.com/2026/10/24/p53-suppressor-trna-cancer-brake-preclinical-en/2026-10-24T18:07:08+03:30https://dibagen.com/2026/10/24/p53-suppressor-trna-cancer-brake-preclinical-fa/2026-10-24T18:07:20+03:30https://dibagen.com/2026/10/24/p53-suppressor-trna-cancer-brake-preclinical-ar/2026-10-24T18:07:26+03:30https://dibagen.com/2026/10/25/invika-selective-t-cell-immunotherapy-start-001-en/2026-10-24T22:30:40+03:30https://dibagen.com/2026/10/25/invika-selective-t-cell-immunotherapy-start-001-fa/2026-10-24T22:31:00+03:30https://dibagen.com/2026/10/25/invika-selective-t-cell-immunotherapy-start-001-ar/2026-10-24T22:31:04+03:30https://dibagen.com/2026/10/25/circular-rna-aquaporin-dry-mouth-rxrg001-en/2026-10-25T11:35:02+03:30https://dibagen.com/2026/10/25/circular-rna-aquaporin-dry-mouth-rxrg001-fa/2026-10-25T11:35:07+03:30https://dibagen.com/2026/10/25/circular-rna-aquaporin-dry-mouth-rxrg001-ar/2026-10-25T11:35:11+03:30https://dibagen.com/2026/10/25/ror2-car-t-aml-selective-target-preclinical-en/2026-10-25T11:36:39+03:30https://dibagen.com/2026/10/25/ror2-car-t-aml-selective-target-preclinical-fa/2026-10-25T11:37:50+03:30https://dibagen.com/2026/10/25/ror2-car-t-aml-selective-target-preclinical-ar/2026-10-25T11:39:00+03:30https://dibagen.com/2026/10/26/linear-cap-independent-rna-cancer-vaccine-review-en/2026-10-26T11:53:51+03:30https://dibagen.com/2026/10/26/linear-cap-independent-rna-cancer-vaccine-review-fa/2026-10-26T11:53:58+03:30https://dibagen.com/2026/10/26/linear-cap-independent-rna-cancer-vaccine-review-ar/2026-10-26T11:54:09+03:30https://dibagen.com/2026/10/26/dostarlimab-azur1-rectal-cancer-organ-preservation-en/2026-10-26T11:54:15+03:30https://dibagen.com/2026/10/26/dostarlimab-azur1-rectal-cancer-organ-preservation-fa/2026-10-26T11:54:25+03:30https://dibagen.com/2026/10/26/dostarlimab-azur1-rectal-cancer-organ-preservation-ar/2026-10-26T11:54:32+03:30https://dibagen.com/2026/10/27/mrna-lnp-post-endosomal-cargo-release-en/2026-10-27T13:49:09+03:30https://dibagen.com/2026/10/27/mrna-lnp-post-endosomal-cargo-release-fa/2026-10-27T13:49:16+03:30https://dibagen.com/2026/10/27/mrna-lnp-post-endosomal-cargo-release-ar/2026-10-27T13:49:21+03:30https://dibagen.com/2026/10/27/nynrin-leukemia-stem-cells-oxidative-stress-en/2026-10-27T13:49:26+03:30https://dibagen.com/2026/10/27/nynrin-leukemia-stem-cells-oxidative-stress-fa/2026-10-27T13:49:31+03:30https://dibagen.com/2026/10/27/nynrin-leukemia-stem-cells-oxidative-stress-ar/2026-10-27T13:49:35+03:30https://dibagen.com/2026/10/28/ispy22-breast-cancer-immune-signature-treatment-reduction-en/2026-10-28T08:35:33+03:30https://dibagen.com/2026/10/28/ispy22-breast-cancer-immune-signature-treatment-reduction-fa/2026-10-28T08:35:33+03:30https://dibagen.com/2026/10/28/ispy22-breast-cancer-immune-signature-treatment-reduction-ar/2026-10-28T08:35:33+03:30https://dibagen.com/2026/10/28/liver-cancer-rna-modification-metabolism-review-en/2026-10-28T08:35:33+03:30https://dibagen.com/2026/10/28/liver-cancer-rna-modification-metabolism-review-fa/2026-10-28T08:35:33+03:30https://dibagen.com/2026/10/28/liver-cancer-rna-modification-metabolism-review-ar/2026-10-28T08:35:33+03:30https://dibagen.com/2026/10/29/mettl1-stm9005-trna-cancer-preclinical-en/2026-10-29T23:38:14+03:30https://dibagen.com/2026/10/29/mettl1-stm9005-trna-cancer-preclinical-fa/2026-10-29T23:38:20+03:30https://dibagen.com/2026/10/29/mettl1-stm9005-trna-cancer-preclinical-ar/2026-10-29T23:38:23+03:30https://dibagen.com/2026/10/31/degradaball-silica-mrna-carrier-phase1-en/2026-10-31T09:01:51+03:30https://dibagen.com/2026/10/31/degradaball-silica-mrna-carrier-phase1-fa/2026-10-31T09:01:56+03:30https://dibagen.com/2026/10/31/degradaball-silica-mrna-carrier-phase1-ar/2026-10-31T09:01:59+03:30